Palantir stock up after better-than-expected quarterly earnings
For the quarter ended in September, Palantir reported revenue of $289 million, topping the $279.3 million expected. In the quarter, the revenue grew by 52%.
On the other hand, Palantir reported a loss of 94 cents per share. During the same time last year, the loss came in at 24 cents per share.
The Palo Alto-based company reported an operating income of $73.1 million. During the quarter, Palantir said that it had closed “fifteen deals with new and existing customers, each worth $5 million or more in total contract value, including contracts with the U.S. Army and National Institutes of Health, as well as a contract renewal with one of the world’s largest aerospace companies worth $300 million in total contract value over five years.”
For the future, Palantir expects its revenue to reach $300 million, while the market is looking for $296 million.
Following the news, the company’s stock price went up 2.3%.
Read more about Palantir here!
Sources: finance.yahoo.com, investors.com
This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation or the particular needs of any recipient.
You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.
This information may not be published, circulated, reproduced or distributed in whole or in part to any other person without the Company’s prior written consent. Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of za.capex.com
JME Financial Services (Pty) Ltd trading as ZA.CAPEX.COM acts as intermediary between the investor and Magnasale Trading Ltd, the counterparty to the contract for difference purchased by the Investor via ZA.CAPEX.COM, authorised & regulated by the Cyprus Securities and Exchange Commission with license number 264/15. Magnasale Trading Ltd is the principal to the CFD purchased by investors.